These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 26721934)

  • 1. TRIO loss of function is associated with mild intellectual disability and affects dendritic branching and synapse function.
    Ba W; Yan Y; Reijnders MR; Schuurs-Hoeijmakers JH; Feenstra I; Bongers EM; Bosch DG; De Leeuw N; Pfundt R; Gilissen C; De Vries PF; Veltman JA; Hoischen A; Mefford HC; Eichler EE; Vissers LE; Nadif Kasri N; De Vries BB
    Hum Mol Genet; 2016 Mar; 25(5):892-902. PubMed ID: 26721934
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autism Spectrum Disorder/Intellectual Disability-Associated Mutations in Trio Disrupt Neuroligin 1-Mediated Synaptogenesis.
    Tian C; Paskus JD; Fingleton E; Roche KW; Herring BE
    J Neurosci; 2021 Sep; 41(37):7768-7778. PubMed ID: 34353896
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An autism spectrum disorder-related de novo mutation hotspot discovered in the GEF1 domain of Trio.
    Sadybekov A; Tian C; Arnesano C; Katritch V; Herring BE
    Nat Commun; 2017 Sep; 8(1):601. PubMed ID: 28928363
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of autism spectrum disorder-related pathogenic trio variants by a novel structure-based approach.
    Rao S; Sadybekov A; DeWitt DC; Lipka J; Katritch V; Herring BE
    Mol Autism; 2024 Apr; 15(1):12. PubMed ID: 38566250
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rho GTPase signaling at the synapse: implications for intellectual disability.
    Ba W; van der Raadt J; Nadif Kasri N
    Exp Cell Res; 2013 Sep; 319(15):2368-74. PubMed ID: 23769912
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel loss-of-function variants in TRIO are associated with neurodevelopmental disorder: case report.
    Schultz-Rogers L; Muthusamy K; Pinto E Vairo F; Klee EW; Lanpher B
    BMC Med Genet; 2020 Nov; 21(1):219. PubMed ID: 33167890
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trio Haploinsufficiency Causes Neurodevelopmental Disease-Associated Deficits.
    Katrancha SM; Shaw JE; Zhao AY; Myers SA; Cocco AR; Jeng AT; Zhu M; Pittenger C; Greer CA; Carr SA; Xiao X; Koleske AJ
    Cell Rep; 2019 Mar; 26(10):2805-2817.e9. PubMed ID: 30840899
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Opposite Modulation of RAC1 by Mutations in TRIO Is Associated with Distinct, Domain-Specific Neurodevelopmental Disorders.
    Barbosa S; Greville-Heygate S; Bonnet M; Godwin A; Fagotto-Kaufmann C; Kajava AV; Laouteouet D; Mawby R; Wai HA; Dingemans AJM; Hehir-Kwa J; Willems M; Capri Y; Mehta SG; Cox H; Goudie D; Vansenne F; Turnpenny P; Vincent M; Cogné B; Lesca G; Hertecant J; Rodriguez D; Keren B; Burglen L; Gérard M; Putoux A; ; Cantagrel V; Siquier-Pernet K; Rio M; Banka S; Sarkar A; Steeves M; Parker M; Clement E; Moutton S; Tran Mau-Them F; Piton A; de Vries BBA; Guille M; Debant A; Schmidt S; Baralle D
    Am J Hum Genet; 2020 Mar; 106(3):338-355. PubMed ID: 32109419
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ten new cases further delineate the syndromic intellectual disability phenotype caused by mutations in DYRK1A.
    Bronicki LM; Redin C; Drunat S; Piton A; Lyons M; Passemard S; Baumann C; Faivre L; Thevenon J; Rivière JB; Isidor B; Gan G; Francannet C; Willems M; Gunel M; Jones JR; Gleeson JG; Mandel JL; Stevenson RE; Friez MJ; Aylsworth AS
    Eur J Hum Genet; 2015 Nov; 23(11):1482-7. PubMed ID: 25920557
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incorrect dosage of IQSEC2, a known intellectual disability and epilepsy gene, disrupts dendritic spine morphogenesis.
    Hinze SJ; Jackson MR; Lie S; Jolly L; Field M; Barry SC; Harvey RJ; Shoubridge C
    Transl Psychiatry; 2017 May; 7(5):e1110. PubMed ID: 28463240
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chromosome 1p21.3 microdeletions comprising DPYD and MIR137 are associated with intellectual disability.
    Willemsen MH; Vallès A; Kirkels LA; Mastebroek M; Olde Loohuis N; Kos A; Wissink-Lindhout WM; de Brouwer AP; Nillesen WM; Pfundt R; Holder-Espinasse M; Vallée L; Andrieux J; Coppens-Hofman MC; Rensen H; Hamel BC; van Bokhoven H; Aschrafi A; Kleefstra T
    J Med Genet; 2011 Dec; 48(12):810-8. PubMed ID: 22003227
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Kirrel3-Mediated Synapse Formation Is Attenuated by Disease-Associated Missense Variants.
    Taylor MR; Martin EA; Sinnen B; Trilokekar R; Ranza E; Antonarakis SE; Williams ME
    J Neurosci; 2020 Jul; 40(28):5376-5388. PubMed ID: 32503885
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distinct Pathogenic Genes Causing Intellectual Disability and Autism Exhibit a Common Neuronal Network Hyperactivity Phenotype.
    Frega M; Selten M; Mossink B; Keller JM; Linda K; Moerschen R; Qu J; Koerner P; Jansen S; Oudakker A; Kleefstra T; van Bokhoven H; Zhou H; Schubert D; Nadif Kasri N
    Cell Rep; 2020 Jan; 30(1):173-186.e6. PubMed ID: 31914384
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of novel neuronal isoforms of the Rho-GEF Trio.
    Portales-Casamar E; Briançon-Marjollet A; Fromont S; Triboulet R; Debant A
    Biol Cell; 2006 Mar; 98(3):183-93. PubMed ID: 16033331
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The intellectual disability PAK3 R67C mutation impacts cognitive functions and adult hippocampal neurogenesis.
    Castillon C; Gonzalez L; Domenichini F; Guyon S; Da Silva K; Durand C; Lestaevel P; Vaillend C; Laroche S; Barnier JV; Poirier R
    Hum Mol Genet; 2020 Jul; 29(12):1950-1968. PubMed ID: 31943058
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trio gene is required for mouse learning ability.
    Zong W; Liu S; Wang X; Zhang J; Zhang T; Liu Z; Wang D; Zhang A; Zhu M; Gao J
    Brain Res; 2015 May; 1608():82-90. PubMed ID: 25727174
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autism and Intellectual Disability-Associated KIRREL3 Interacts with Neuronal Proteins MAP1B and MYO16 with Potential Roles in Neurodevelopment.
    Liu YF; Sowell SM; Luo Y; Chaubey A; Cameron RS; Kim HG; Srivastava AK
    PLoS One; 2015; 10(4):e0123106. PubMed ID: 25902260
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterisation of de novo MAPK10/JNK3 truncation mutations associated with cognitive disorders in two unrelated patients.
    Kunde SA; Rademacher N; Tzschach A; Wiedersberg E; Ullmann R; Kalscheuer VM; Shoichet SA
    Hum Genet; 2013 Apr; 132(4):461-71. PubMed ID: 23329067
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TRIO-related intellectual disability with microcephaly: a case report of a patient with novel clinical findings.
    Bevilacqua F; Alberto G; Duarte SP; Serra M; Basterra J; Espeche L; Cerretini RI; Solari AP
    Clin Dysmorphol; 2021 Jan; 30(1):22-26. PubMed ID: 33038108
    [No Abstract]   [Full Text] [Related]  

  • 20. Involvement of the kinesin family members KIF4A and KIF5C in intellectual disability and synaptic function.
    Willemsen MH; Ba W; Wissink-Lindhout WM; de Brouwer AP; Haas SA; Bienek M; Hu H; Vissers LE; van Bokhoven H; Kalscheuer V; Nadif Kasri N; Kleefstra T
    J Med Genet; 2014 Jul; 51(7):487-94. PubMed ID: 24812067
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.